Increased cardiometabolic risk and prevalence of ascending aorta dilation in patients with nonfunctioning adrenal incidentaloma: a retrospective propensity score-matched study-Reference-Cited by-同舟云学术

Increased cardiometabolic risk and prevalence of ascending aorta dilation in patients with nonfunctioning adrenal incidentaloma: a retrospective propensity score-matched study

Published:2024-08-01 Issue: Volume: Page:
ISSN:0916-9636
Container-title:Hypertension Research
language:en
Short-container-title:Hypertens Res

Author:

Parasiliti-Caprino Mirko,Roux Anna,Campioni Lorenzo,Procopio Matteo,Arata Stefano,Giannelli Jacopo,Bollati Martina,Bima Chiara,Lopez Chiara,Bioletto Fabio,Ghigo Ezio,Arvat Emanuela,Maccario Mauro,Giordano Roberta

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41440-024-01807-3.pdf

Reference43 articles.

1. Fassnacht M, Tsagarakis S, Terzolo M, Tabarin A, Sahdev A, Newell-Price J, et al. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2023;189:G1–G42. https://doi.org/10.1093/ejendo/lvad066.

2. Erbil Y, Ozbey N, Barbaros U, Unalp HR, Salmaslioglu A, Ozarmagan S. Cardiovascular risk in patients with nonfunctional adrenal incidentaloma: myth or reality? World J Surg. 2009;33:2099–105. https://doi.org/10.1007/S00268-009-0178-0.

3. Arruda M, Mello Ribeiro Cavalari E, Pessoa De Paula M, Fernandes Cordeiro de Morais F, Furtado Bilro G, Alves Coelho MC, et al. The presence of nonfunctioning adrenal incidentalomas increases arterial hypertension frequency and severity, and is associated with cortisol levels after dexamethasone suppression test. J Hum Hypertens. 2017;32:3–11. https://doi.org/10.1038/S41371-017-0011-4.

4. Araujo‐Castro M. Cardiometabolic profile and urinary metabolomic alterations in non‐functioning adrenal incidentalomas: A review. Clin Endocrinol. 2022;97:693–701. https://doi.org/10.1111/cen.14745.

5. Lopez D, Luque-Fernandez MA, Steele A, Adler GK, Turchin A, Vaidya A. Nonfunctional” Adrenal Tumors and the Risk for Incident Diabetes and Cardiovascular Outcomes: A Cohort Study. Ann Intern Med. 2016;165:533–42. https://doi.org/10.7326/M16-0547.